Five tracks. Graded by evidence, not hype.
Each track sorts a research area from FDA-approved to early preclinical, so you always know which tier you are looking at.
The compounds behind the fat-loss results everyone is talking about.
Users report significant weight loss on GLP-1 compounds. Here is what they report, what the trials prove, and which compounds are approved versus experimental.
The compounds people research to age slower.
Longevity attracts the biggest promises in the space. This track keeps the focus on what the evidence supports, compound by compound.
The compounds people research for GH signaling and body composition.
Endocrine peptides deserve more caution than hype. This track separates approved clinical use, emerging evidence, and experimental research.
The compounds people research for skin, collagen, and pigmentation.
Users report visible skin improvement with GHK-Cu. This track shows what the evidence supports, and flags where the data belongs to an ingredient, not a branded blend.
The compounds people research for sleep, focus, and stress resilience.
Neuroregulatory peptides are easy to oversell because the outcomes are personal. This track keeps the focus on mechanism and what is actually known.